TGFB1 and Hepatic steatosis: In that particular study, SAA was found to alleviate the lesions of hepatic steatosis and fibrosis in a streptozotocin-induced diabetes model administered a high-fat diet, via inhibition of α-smooth-muscle-actin (α-SMA) and TGF-β in the liver [26].